Depression and cardiovascular disease: SADHART results


The SADHART (Sertraline Antidepressant Heart Attack Randomized Trial) study was a placebo-controlled trial of the SSRI sertraline in 369 patients with acute coronary syndrome who met diagnostic criteria for major depression (Glassman et al. Arch Gen Psychiatry 2009; 66: 102-1029).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page